Filed by
Charles River Laboratories International, Inc.
pursuant
to Rule 14a-12
of the
Securities Exchange Act of 1934
Subject
Company: Charles River Laboratories International, Inc.
(Commission
File No.: 001-15943)
July 9,
2010
Dear
Shareholder:
We have
previously sent to you proxy materials for the special meeting of shareholders
of Charles River Laboratories International, Inc., to be held on August 5,
2010. The Charles
River board of directors unanimously recommends that you vote FOR the issuance
of Charles River common stock in connection with the transaction to acquire WuXi
PharmaTech (Cayman) Inc.
Your vote is important, no
matter how many or how few shares you may own. Whether or not you have
already done so, please vote TODAY by telephone, via the Internet, or by signing, dating
and returning the enclosed proxy card in the envelope
provided.
Very
truly yours,
James C.
Foster
Chairman, Chief Executive
Officer and President
|
REMEMBER:
You
can vote your shares by telephone, or via the
Internet.
Please
follow the easy instructions on the enclosed proxy card.
If
you have any questions, or need assistance in voting
your
shares, please call our proxy solicitor,
INNISFREE
M&A INCORPORATED
TOLL-FREE,
at 1-888-750-5834.
|
Additional
Information
This
document may be deemed to be solicitation material in respect of the proposed
combination of Charles River and WuXi. In connection with the proposed
transaction, Charles River has filed a definitive proxy statement with the SEC.
Before making any voting or investment decisions, investors and security holders
are urged to read the definitive proxy statement and any other relevant
documents filed with the SEC because they will contain important information.
The definitive proxy statement will be mailed to the shareholders of Charles
River seeking their approval of the proposed transaction. Charles River’s
shareholders will also be able to obtain a copy of the definitive proxy
statement free of charge by directing a request to:
Charles
River Laboratories, 251 Ballardvale Street, Wilmington,
MA 01887,
Attention: General Counsel.
In
addition, the definitive proxy statement is available free of charge at the
SEC’s website, www.sec.gov or shareholders may access copies of the
documentation filed with the SEC by Charles River on Charles River’s website
at:
www.criver.com/specialwuxi2010.
Charles
River, WuXi and their respective directors and executive officers and other
members of management may be deemed to be participants in the solicitation of
proxies in respect of the proposed transaction. Information regarding Charles
River’s directors and executive officers is available in Charles River’s proxy
statement for its 2010 annual meeting of shareholders, which was filed with the
SEC on March 30, 2010. Information regarding the interests of Charles River’s
directors and certain members of Charles River’s management in the proposed
transaction is set forth in the definitive proxy statement filed with the SEC.
Information regarding WuXi’s directors and executive officers is available in
WuXi’s annual report on Form 20-F for the fiscal year ended December 31, 2009,
which was filed with the SEC on April 23, 2010. Information regarding the
interests of WuXi’s directors and certain members of WuXi’s management in the
proposed transaction is available in WuXi’s approved scheme document, which was
filed on Form 6-K with the SEC on June 29, 2010.
This
document does not constitute an offer of any securities for sale or a
solicitation of an offer to buy any securities. The Charles River shares to be
issued in the proposed transaction have not been and will not be registered
under the Securities Act of 1933, as amended (the “Securities Act”), and may not
be offered or sold in the United States absent registration or an applicable
exemption from registration requirements. Charles River intends to issue such
Charles River shares pursuant to the exemption from registration set forth in
Section 3(a)(10) of the Securities Act.